Characteristics, predictors and consequences of tuberculosis treatment interruption: A multicentre retrospective cohort study
- 12 March 2024
- journal article
- research article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 29 (5) , 434-445
Abstract
Objectives: Treatment interruption is associated with poor tuberculosis (TB) treatment outcomes and increased drug resistance. To address the issue, we aimed to investigate the characteristics, predictors and consequences of treatment interruption.Methods: We conducted a retrospective cohort study by retrieving 4 years (2018–2021) of TB patients' records at 10 public health clinics in Sarawak, Malaysia. Adult patients (≥18 years) with drug‐susceptible TB were selected. Treatment interruption was defined as ≥2 weeks of cumulative interruption during treatment. The Chi‐square test, Mann–Whitney U test, Kaplan–Meier and Cox proportional hazards regression were used to analyse the data, with p < 0.05 being considered statistically significant.Results: Out of 2953 eligible patients, 475 (16.1%) experienced TB treatment interruption. Interruptions were most frequent during the intensive phase (46.9%, n = 223), with the greatest risk within the first 4 weeks of treatment. The median time to interruption was 2 weeks in the intensive phase and the cumulative interruption probability at the end of the intensive phase was 12.9%. Notably, treatment interruption occurred during both intensive and continuation phases for 144 patients (30.3%), while the remaining 108 (22.7%) experienced interruptions only during the continuation phase with a median time to interruption of 16 weeks. Three predictors were identified to increase the risk of treatment interruption: adverse drug reaction (aHR = 8.53, 95% Cl: 6.73–10.82), smoking (aHR = 2.67, 95% Cl: 2.03–3.53) and illicit drug use (aHR = 1.88, 95% Cl: 1.03–3.45). Conversely, underlying diabetes was associated with a reduced likelihood of treatment interruption (aHR = 0.72, 95% Cl: 0.58–0.90). Treatment interruption led to significant differences in treatment restarts (62.3% vs. 0.7%), changes in medications (47.8% vs. 4.9%), prolonged treatment duration (247 days [IQR = 105] vs. 194 days [IQR = 44.3]) and lower successful outcomes (86.5% vs. 99.9%).Conclusion: Understanding the temporal characteristics, predictors and negative consequences of treatment interruption can guide the development of time‐relevant approaches to mitigate the problem.Keywords
This publication has 18 references indexed in Scilit:
- Tuberculosis: current challenges and beyondBreathe, 2023
- Risk factors for early TB treatment interruption among newly diagnosed patients in MalaysiaScientific Reports, 2022
- Effect of smoking on treatment outcome among tuberculosis patients in Malaysia; a multicenter studyBMC Public Health, 2020
- Determinants of unsuccessful treatment outcomes and mortality among tuberculosis patients in Malaysia: A registry-based cohort studyPLOS ONE, 2020
- Adverse drug reactions in tuberculosis and managementIndian Journal of Tuberculosis, 2019
- Establishing a cohort in a developing country: Experiences of the diabetes-tuberculosis treatment outcome cohort studyJournal of Epidemiology and Global Health, 2017
- Using Survival Analysis to Identify Risk Factors for Treatment Interruption among New and Retreatment Tuberculosis Patients in KenyaPLOS ONE, 2016
- Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisClinical Infectious Diseases, 2016
- Nonadherence in Tuberculosis Treatment: Predictors and Consequences in New York CityThe American Journal of Medicine, 1997
- A simulation study of the number of events per variable in logistic regression analysisJournal of Clinical Epidemiology, 1996